1. Home
  2. Disease & Disorders
  3. Cincinnati, OH
  4. Cure Starts Now

Cure Starts Now

Cure Starts Now has an America's Best Score of 52 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Cincinnati, OH
  • Tax-exempt since 2007
  • EIN: 26-0269131
thecurestartsnow.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
52OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Cure Starts Now is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G48). Contributions are tax-deductible.

10280 Chester Rd, Cincinnati, OH 45215-1200

Among the 20 scored disease & disorders organizations in Cincinnati, Cure Starts Now holds 0.9 months of operating reserves (peer median 14.6 months), runs a typical yearly deficit of 3.5% (peers: surplus of 0.8%), and has grown spending 11.7% a year (peers: grown spending 6.3% a year).

In fiscal year 2025 it reported $5,655,854 in revenue and $8,438,186 in expenses, with contributions making up 79.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

To educate, aid, and fund cures for cancer, starting first with pediatric brain cancer.

Largest programs · fiscal year 2025

  • In its efforts to focus on those cancers that present the greatest opportunities for an encompassing cancer cure, the foundation annually awards research grants to institutions and medical professionals. Typically, grants awarded have a focus on pediatric brain cancers, as this was the origin of the foundation's philosophy. Grant applications will be judged on a peer-reviewed basis with the founda… Read more

    In its efforts to focus on those cancers that present the greatest opportunities for an encompassing cancer cure, the foundation annually awards research grants to institutions and medical professionals. Typically, grants awarded have a focus on pediatric brain cancers, as this was the origin of the foundation's philosophy. Grant applications will be judged on a peer-reviewed basis with the foundation's medical advisory council, which is comprised of top oncologists and researchers from around the world, as well as parent advocates. Grants are judged based on multiple criteria including scientific merit, disease impact, innovation, feasibility, and expertise of the investigator.

    $5,076,088 spent · 67.6% of program spending
  • Family support and awareness funds provide emotional support, mechanisms to honor their child's legacy and other assistance for families battling pediatric cancer. This includes information websites, trial discovery tools, patient assistance and programs to feature patients with the intention of builing local support and awareness. $1,551,816 spent · 20.7% of program spending
  • The brain cancer symposium (formerly dipg/dmg/medulloblastoma symposium) is the world's foremost and largest international medical research conference focusing on diffuse intrinsic pontine glioma (dipg), diffuse midline glioma (dmg) and medulloblastoma. Researchers, doctors, families and foundations come from across the globe to participate in this innovative event. The biennial symposium originat… Read more

    The brain cancer symposium (formerly dipg/dmg/medulloblastoma symposium) is the world's foremost and largest international medical research conference focusing on diffuse intrinsic pontine glioma (dipg), diffuse midline glioma (dmg) and medulloblastoma. Researchers, doctors, families and foundations come from across the globe to participate in this innovative event. The biennial symposium originated in 2011 and has continued to grow over the years. In 2025 in banff british columbia, canada, more than 200 of the leading experts, researchers and doctors in dipg, dmg, and medulloblastoma attended. The brain cancer symposium brings the researchers, doctors, foundations and families together in this collaborative event is a unique approach to creating and funding new and innovative research.

    $878,880 spent · 11.7% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 89¢ went to programs, 1¢ to management and 10¢ to fundraising.

  • Programs $7,506,784
  • Management $111,546
  • Fundraising $819,856

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score52 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves0.9 mo; 5.4 mo in cash0.6 / 25
Financial balance (median margin)−3.5%10 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+11.7% / yr13.3 / 15
Track record19 years7.6 / 10
Debt load85.4% of assets0 / 10
Total51.6 → 52
Spending on programs
Not scored; America's Best needs 65%+
89%Meets

Compared with Cincinnati peers

MeasureThis organizationPeer median
Operating reserves0.9 mo14.6 mo
Typical margin−3.5%+0.8%
Spending growth+11.7% / yr+6.3% / yr
Debt load85.4%2.0%

Peers: the 20 Cincinnati disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$5,655,854Fiscal year 20252022: $5,231,63020222023: $5,080,69320232024: $5,367,38020242025: $5,655,8542025
Expenses$8,438,186Fiscal year 20252022: $6,057,97420222023: $4,760,30720232024: $4,381,04320242025: $8,438,1862025
Total assets$4,317,740Fiscal year 20252022: $2,625,69620222023: $4,130,90720232024: $4,248,12020242025: $4,317,7402025
Total liabilities$3,686,759Fiscal year 20252022: $612,50920222023: $1,703,93120232024: $834,80720242025: $3,686,7592025
Fiscal year ending December 2025
Revenue$5,655,854
Expenses$8,438,186
Net income−$2,782,332
Net assets$630,981

Notable sources of revenue

Percent of total revenue
Contributions$4,510,392
Program services$0
Investment income$16,962
Other (net)$1,128,500

Assets / debt

Total assets$4,317,740
Total liabilities$3,686,759
Net assets$630,981

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$5,367,380
Expenses$4,381,043
Net income$986,337
Net assets$3,413,313

Notable sources of revenue

Percent of total revenue
Contributions$4,252,213
Program services$0
Investment income$16,804
Other (net)$1,098,363

Assets / debt

Total assets$4,248,120
Total liabilities$834,807
Net assets$3,413,313

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$5,080,693
Expenses$4,760,307
Net income$320,386
Net assets$2,426,976

Notable sources of revenue

Percent of total revenue
Contributions$3,674,963
Program services$0
Investment income$0
Other (net)$1,405,730

Assets / debt

Total assets$4,130,907
Total liabilities$1,703,931
Net assets$2,426,976

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$5,231,630
Expenses$6,057,974
Net income−$826,344
Net assets$2,013,187

Notable sources of revenue

Percent of total revenue
Contributions$4,315,043
Program services$0
Investment income$0
Other (net)$916,587

Assets / debt

Total assets$2,625,696
Total liabilities$612,509
Net assets$2,013,187

Compensation

Officers and key employees$237,081
Share of expenses3.9%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?